Despite development challenges such as rising R&D costs, increasingly strict regulatory requirements, and safety concerns, drug developers have cause for optimism, according to the Tufts Center for the Study of Drug Development. According to the center’s most recent study, the contributing factors for this optimism include the use of new technologies to reduce late-stage development failures and control costs, reliance on global outsourcing to speed development and reduce costs, a...